Amiloride HCl - CAS 2016-88-8
Catalog number:
2016-88-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C6H8ClN7O.HCl
Molecular Weight:
266.09
COA:
Inquire
Targets:
Sodium Channel
Description:
Amiloride HCl is a relatively selective inhibitor of the epithelial sodium channel (ENaC), used in the management of hypertension and congestive heart failure.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.5'-Substituted amiloride derivatives as allosteric modulators binding in the sodium ion pocket of the adenosine A2A receptor.
Massink A, Louvel JA, Adlere I, van Veen C, Huisman BJ, Dijksteel GS, Guo D, Lenselink EB, Buckley BJ, Matthews H, Ranson M, Kelso MJ, IJzerman AP. J Med Chem. 2016 Apr 28. [Epub ahead of print]
The sodium ion site is an allosteric site conserved amongst many G protein-coupled receptors (GPCRs). Amiloride 1 and 5-(N,N-hexamethylene)amiloride 2 (HMA) supposedly bind in this sodium ion site and can influence orthosteric ligand binding. The availability of a high resolution X-ray crystal structure of the human adenosine A2A receptor (hA2AAR), in which the allosteric sodium ion site was elucidated, makes it an appropriate model receptor for investigating the allosteric site. In this study, we report the synthesis and evaluation of novel 5'-substituted amiloride derivatives as hA2AAR allosteric antagonists. Potency of the amiloride derivatives was assessed by their ability to displace the orthosteric radioligand [3H]4-(2-((7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a]-[1,3,5]triazin-5-yl)amino)ethyl)phenol ([3H]ZM-241,385) from both the wild-type and sodium ion site W246A mutant hA2AAR. 4-Ethoxyphenethyl substituted amiloride 12l was found to be more potent than both amiloride and HMA, and the potency-shift between the wild-type and mutated receptor confirmed its likely binding to the sodium ion site.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Sodium Channel Products


CAS 550-83-4 Propoxycaine hydrochloride

Propoxycaine hydrochloride
(CAS: 550-83-4)

Propoxycaine hydrochloride is the hydrochloride salt form of Propoxycaine used to control the pain of intramuscular injection of penicillin as well as in dentis...

CAS 95635-55-5 Ranolazine

Ranolazine
(CAS: 95635-55-5)

Ranolazine is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

CAS 1744-22-5 Riluzole

Riluzole
(CAS: 1744-22-5)

Riluzole is a drug used to treat amyotrophic lateral sclerosis.

CAS 66794-74-9 Encainide Hydrochloride

Encainide Hydrochloride
(CAS: 66794-74-9)

Encainide Hydrochloride is a sodium channel blocker and class Ic antiarrhythmic agent. It is a non-chiral and benzanilide derivative. It blocks voltage-gated so...

CAS 6108-05-0 Lidocaine hydrochloride monohydrate

Lidocaine hydrochloride monohydrate
(CAS: 6108-05-0)

Lidocaine hydrochloride monohydrate is the hydrochloride monohydrate form of lidocaine, which is an aminoethylamide and a prototypical member of the amide class...

CAS 181144-66-1 Co 102862

Co 102862
(CAS: 181144-66-1)

Co 102862, also known as V102862, an orally active anticonvulsant with robust activity, is a potent, broad-spectrum state-dependent inhibitor of mammalian volta...

CAS 84057-84-1 Lamotrigine

Lamotrigine
(CAS: 84057-84-1)

Lamotrigine is an anticonvulsant, inhibiting glutamate release, possibly through inhibition of Na+, K+ and Ca2+ currents.

CAS 630-93-3 Phenytoin Sodium

Phenytoin Sodium
(CAS: 630-93-3)

Phenytoin Sodium is a potent multi-channel blocker, which blocks Na+, K+ and Ca 2+ channels and selectively blocks persistent INaP over shorter INaP actions.

Nav1.7 inhibitor
(CAS: 1355631-24-1)

Nav1.7 inhibitor is a Voltage-gated sodium channel inhibitor that have probable effect in pain therapy and local anaesthesia.

PF-04856264
(CAS: 1235397-05-3)

This active molecular is a human Nav1.7 voltage gated sodium channel inhibitor with the IC50 value of 28 nM. PF-04856264 inhibits the Nav channel by interacting...

Nav1.7-IN-2
(CAS: 1332295-35-8)

Nav1.7-IN-2, a voltage-gated sodium channels, could be probably effective in chronic pain therapy. IC50: 80 nM.

CAS 5370-01-4 Mexiletine Hydrochloride

Mexiletine Hydrochloride
(CAS: 5370-01-4)

Mexiletine HCl belongs to Class IB anti-arrhythmic group of medicines, inhibits sodium channels to reduce the inward sodium current.

CAS 166196-11-8 CGP-47292

CGP-47292
(CAS: 166196-11-8)

CGP-47292, a triazole compound, has been found to be a metabolite of CGP-33101 that could be used agaist Lennox-Gastaut syndrome as a Sodium Channel antagonist.

Funapide
(CAS: 1259933-16-8)

Funapide is a Nav1.7 and Nav1.8 voltage-gated sodium channel inhibitor under the development by Xenon Pharmaceuticals and Teva Pharmaceutical Industries. It is ...

CAS 892546-37-1 PH-064

PH-064
(CAS: 892546-37-1)

PH-064 is a sodium channel inhibitor. It is extracted from patent FR 2879460 A1.

Sodium Channel inhibitor 1
(CAS: 1198117-23-5)

Sodium Channel inhibitor 1, a 3-Oxoisoindoline-1-carboxamide derivative, is an effective voltage-gated sodium channel blocker that could be used for pain treatm...

Evenamide
(CAS: 1092977-61-1)

Evenamide is a selective voltage-gated sodium and​/or calcium channel modulator, including subtypes Nav1.3, Nav1.7, and Nav1.8. It may be potentia useful in pre...

PD 122860
(CAS: 122576-86-7)

This active molecular is a calcium channel antagonist with sodium channel stimulating property as a dihydropyridine. PD 122860 can increase left ventricular con...

CAS 57-41-0 Phenytoin

Phenytoin
(CAS: 57-41-0)

Phenytoin is believed to protect against seizures by causing voltage-dependent block of voltage gated sodium channels.

CAS 132112-35-7 Ropivacaine Hydrochloride

Ropivacaine Hydrochloride
(CAS: 132112-35-7)

Ropivacaine hydrochloride is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.

Chemical Structure

CAS 2016-88-8 Amiloride HCl

Quick Inquiry

Verification code

Featured Items